default author photo

Francois-Xavier Danlos

Gustave Roussy

Villejuif

France

SCHOLARLY PAPERS

2

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Impact of Immunosuppressive Agents on the Management of Immune-Related Adverse Events of Immune Checkpoint Blockers

Number of pages: 20 Posted: 02 Feb 2024
University of Paris-Saclay, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, University Paris Sud, Université Paris Saclay, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Gustave Roussy, Gustave Roussy, Gustave Roussy Cancer Campus, University of Paris-Saclay and University of Paris-Saclay
Downloads 48 (1,086,013)

Abstract:

Loading...

immune checkpoint blocker, corticosteroid, immunosuppressant agent, immune-related adverse events

2.

Feasibility and clinical relevance of the G-CODE in older adults treated in Phase 1 Clinical Trials at Gustave Roussy

Number of pages: 15 Posted: 15 Oct 2025
Gustave Roussy - Drug Development Department (DITEP), affiliation not provided to SSRN, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, University of Paris-Saclay - Department of Hematology, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 34 (1,263,436)

Abstract:

Loading...

G-CODE, geriatric assessment, phase 1 clinical trials, older adults, feasibility, Toxicity